| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.05. | InnovAge appoints Jennifer Browne as president and COO | 1 | Investing.com | ||
| 12.05. | InnovAge Holding Corp. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.05. | InnovAge projects $950M-$975M revenue and $85M-$90M adjusted EBITDA for fiscal 2026 amid early 2027 rate pressure signals | 1 | Seeking Alpha | ||
| 06.05. | Full Transcript: InnovAge Holding Q3 2026 Earnings Call | 3 | Benzinga.com | ||
| 05.05. | InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026 | 102 | GlobeNewswire (Europe) | DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| 04.05. | Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality? | 1 | Zacks | ||
| 06.04. | Take the Zacks Approach to Beat the Markets: Stride, InnovAge, PepsiCo in Focus | 7 | Zacks | ||
| INNOVAGE Aktie jetzt für 0€ handeln | |||||
| 17.03. | InnovAge Holding Corp. - 8-K, Current Report | 3 | SEC Filings | ||
| 05.02. | InnovAge: Proven Senior Care Model Takes Center Stage at the Capitol | 2 | GlobeNewswire (USA) | ||
| 04.02. | InnovAge raises 2026 revenue guidance to $950M while achieving 9.2% adjusted EBITDA margin | 1 | Seeking Alpha | ||
| 03.02. | InnovAge Holding Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 03.02. | InnovAge Holding Q2 Earnings Report: What Investors Need to Know | 1 | Benzinga.com | ||
| 03.02. | InnovAge GAAP EPS of $0.08 beats by $0.04, revenue of $239.71M beats by $11.41M | 3 | Seeking Alpha | ||
| 03.02. | InnovAge Holding Q2 Earnings Summary & Key Takeaways | 3 | Benzinga.com | ||
| 03.02. | InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025 | 505 | GlobeNewswire (Europe) | DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| 02.02. | Examining the Future: InnovAge Holding's Earnings Outlook | 1 | Benzinga.com | ||
| 29.01. | InnovAge holt zwei frühere Direktoren in den Verwaltungsrat zurück | - | Investing.com Deutsch | ||
| 29.01. | InnovAge Holding Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.01. | InnovAge Expands Board with Appointment of Two Directors | 1 | GlobeNewswire (USA) | ||
| 12.01. | InnovAge Holding Corp. - 8-K, Current Report | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,260 | +1,61 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat Fresenius mit einem Kursziel von 56,60 Euro auf "Overweight" belassen. Die Aktie steht zudem auf der "Analyst Focus List" der US-Bank. Der Nahostkonflikt und... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,32 | -4,20 % | Fast-paced Momentum Stock BrightSpring Health Services, Inc. (BTSG) Is Still Trading at a Bargain | ||
| SIEMENS HEALTHINEERS | 34,800 | +0,43 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,200 | +1,22 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC mit einem Kursziel von 37 Euro auf "Sell" belassen. Anstehende Daten eines Konkurrenzprodukts könnten das Potenzial für optimistischere... ► Artikel lesen | |
| BILLIONTOONE | 100,80 | -3,62 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 52,93 | -5,94 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| ALIGNMENT HEALTHCARE | 15,350 | +1,86 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| VIVOS THERAPEUTICS | 1,105 | +71,82 % | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing | LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| GERRESHEIMER | 26,040 | +0,54 % | Ihre wichtigsten Termine: Alle Blicke auf: Broadcom, Macy's, Lyft, Medtronic, Palantir und Gerresheimer! | © Foto: picture alliance/ASSOCIATED PRESS/Gerresheimer AG - picture alliance/ASSOCIATED PRESS/Gerresheimer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,470 | -1,21 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler veranstaltet das vierte Boston Radionuclide Theranostics Forum | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Konferenz/Sonstiges
Eckert & Ziegler veranstaltet das vierte Boston Radionuclide Theranostics Forum
29.05.2026 / 09:30 CET/CEST
Für... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,700 | +0,23 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PROGYNY | 25,690 | +0,82 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| UNITEDHEALTH | 348,20 | +1,93 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 5,060 | +19,62 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| ALPHA TAU MEDICAL | 9,440 | -10,78 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen |